These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37126535)

  • 1. Effect of alteplase, benzodiazepines and beta-blocker on post-stroke pneumonia: Exploration of VISTA-Acute.
    Phan TG; Beare R; Bath PM; Ievlieva S; Ho S; Ly J; Thrift AG; Srikanth VK; Ma H;
    PLoS One; 2023; 18(5):e0281617. PubMed ID: 37126535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of blood pressure and blood glucose to treatment with recombinant tissue-type plasminogen activator in acute ischemic stroke: evidence from the virtual international stroke trials archive.
    Kerr DM; Fulton RL; Higgins P; Bath PM; Shuaib A; Lyden P; Lees KR;
    Stroke; 2012 Feb; 43(2):399-404. PubMed ID: 22075999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA).
    Mishra NK; Lyden P; Grotta JC; Lees KR;
    Stroke; 2010 Nov; 41(11):2612-7. PubMed ID: 20947852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
    Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
    Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
    Kent DM; Price LL; Ringleb P; Hill MD; Selker HP
    Stroke; 2005 Jan; 36(1):62-5. PubMed ID: 15569865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke.
    Buijs JE; Uyttenboogaart M; Brouns R; de Keyser J; Kamphuisen PW; Luijckx GJ
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):312-6. PubMed ID: 26527412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.
    Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y
    J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke Severity Versus Dysphagia Screen as Driver for Post-stroke Pneumonia.
    Phan TG; Kooblal T; Matley C; Singhal S; Clissold B; Ly J; Thrift AG; Srikanth V; Ma H
    Front Neurol; 2019; 10():16. PubMed ID: 30761063
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation.
    Zhang JB; Ding ZY; Yang Y; Sun W; Hai F; Sui XN; Li XY; Wang HZ; Wang XT; Zheng JL
    Neurol Res; 2010 May; 32(4):353-8. PubMed ID: 20483000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seven-day NIHSS is a sensitive outcome measure for exploratory clinical trials in acute stroke: evidence from the Virtual International Stroke Trials Archive.
    Kerr DM; Fulton RL; Lees KR;
    Stroke; 2012 May; 43(5):1401-3. PubMed ID: 22308254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous fibrinolysis eligibility: a survey of stroke clinicians' practice patterns and review of the literature.
    De Los Rios F; Kleindorfer DO; Guzik A; Ortega-Gutierrez S; Sangha N; Kumar G; Grotta JC; Lee JM; Meyer BC; Schwamm LH; Khatri P;
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2130-2138. PubMed ID: 25113084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
    Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
    Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in neutrophil, lymphocyte, platelet ratios and their relationship with NIHSS after rtPA and/or thrombectomy in ischemic stroke.
    Kömürcü HF; Gözke E; Doğan Ak P; Kalyoncu Aslan I; Salt I; Özgenç Bi Er Çİ
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):105004. PubMed ID: 32689579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes following thrombolytic therapy among patients with prior stroke and diabetes in the Virtual International Stroke Trials Archive (VISTA).
    Mishra NK; Davis SM; Kaste M; Lees KR;
    Diabetes Care; 2010 Dec; 33(12):2531-7. PubMed ID: 20843977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator.
    Wei XE; Zhao YW; Lu J; Li MH; Li WB; Zhou YJ; Li YH
    Acta Radiol; 2015 Sep; 56(9):1119-26. PubMed ID: 25182802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis.
    Wardlaw JM; Sandercock PA; Berge E
    Stroke; 2003 Jun; 34(6):1437-42. PubMed ID: 12730560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia.
    Blum B; Wormack L; Holtel M; Penwell A; Lari S; Walker B; Nathaniel TI
    BMC Womens Health; 2019 Jan; 19(1):11. PubMed ID: 30651099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.